-
EP2061446
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2061446
| EP2061446 - USE OF CDK INHIBITORS FOR THE TREATMENT OF GRANULOCYTE MEDIATED DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.01.2011 Database last updated on 20.12.2024 | Most recent event Tooltip | 21.01.2011 | Application deemed to be withdrawn | published on 23.02.2011 [2011/08] | Applicant(s) | For all designated states University Court of the University of Edinburgh Old College South Bridge Edinburgh / GB | [2009/22] | Inventor(s) | 01 /
ROSSI, Adriano University of Edinburgh Queen's Medical Research Institute 47 Little France Crescent Edinburgh EH16 4TJ / GB | 02 /
HASLETT, Christopher University of Edinburgh Queen's Medical Research Institute 47 Little France Crescent Edinburgh EH16 4JT / GB | [2009/22] | Representative(s) | Main, Malcolm Charles, et al Murgitroyd & Company Immeuble Atlantis 55 Allee Pierre Ziller 06560 Valbonne - Sophia Antipolis / FR | [N/P] |
| Former [2009/22] | Main, Malcolm Charles, et al Murgitroyd & Company Immeuble Atlantis 55 Allee Pierre Ziller 06560 Valbonne - Sophia Antipolis / FR | Application number, filing date | 07789083.8 | 30.07.2007 | [2009/22] | WO2007GB02903 | Priority number, date | GB20060015039 | 28.07.2006 Original published format: GB 0615039 | GB20060016871 | 25.08.2006 Original published format: GB 0616871 | [2009/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008012563 | Date: | 31.01.2008 | Language: | EN | [2008/05] | Type: | A2 Application without search report | No.: | EP2061446 | Date: | 27.05.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.01.2008 takes the place of the publication of the European patent application. | [2009/22] | Search report(s) | International search report - published on: | EP | 27.03.2008 | Classification | IPC: | A61K31/00, A61K31/52, A61K31/55, A61P11/00, A61P11/06, A61P19/02, A61P29/00, A61P37/08 | [2009/22] | CPC: |
A61K31/00 (EP,US);
A61K31/52 (EP,US);
A61K31/55 (EP,US);
A61P11/00 (EP);
A61P11/06 (EP);
A61P19/02 (EP);
A61P29/00 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/22] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | VERWENDUNG VON CDK-HEMMERN ZUR BEHANDLUNG VON GRANULOZYTEN-VERMITTELTEN ERKRANKUNGEN | [2009/22] | English: | USE OF CDK INHIBITORS FOR THE TREATMENT OF GRANULOCYTE MEDIATED DISORDERS | [2009/22] | French: | UTILISATION D'INHIBITEURS DE CDK POUR LE TRAITEMENT DE MALADIES A MEDIATION GRANULOCYTAIRE | [2009/22] | Entry into regional phase | 27.02.2009 | National basic fee paid | 27.02.2009 | Designation fee(s) paid | 27.02.2009 | Examination fee paid | Examination procedure | 27.02.2009 | Amendment by applicant (claims and/or description) | 27.02.2009 | Examination requested [2009/22] | 11.02.2010 | Despatch of a communication from the examining division (Time limit: M06) | 24.08.2010 | Application deemed to be withdrawn, date of legal effect [2011/08] | 28.09.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/08] | Fees paid | Renewal fee | 08.07.2009 | Renewal fee patent year 03 | 26.07.2010 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO03091384 (EIRX THERAPEUTICS LTD [IE], et al) [X] 1-9,11-15,17-24,26-30 * page 1, line 4 - line 7 * * page 8, line 26 - page 9, line 7 * * page 15, line 12 - line 15 * * page 15, line 24 - line 29 *; | [X]WO0152892 (GENZYME CORP [US]) [X] 1-9,11-14,16-24,26-29,31 * page 4, paragraph 3 * * page 11, paragraph 7 - page 12, paragraph 1 *; | [X]WO2004041308 (CYCLACEL LTD [GB], et al) [X] 1-3,6,11,13-18,21,26,28-31 * page 2, line 15 - line 23 * * page 4, line 23 - line 28 * * page 4, line 30 - page 5, line 6 *; | [X]WO2004103958 (UNIV MICHIGAN STATE [US]) [X] 1-9,11-14,16-24,26-29,31 * page 3, paragraph 7 - page 4, paragraph 8 * * page 31, paragraph 81 *; | [X]US2005154046 (WANG LONGGUI [US], et al) [X] 1-9,11-14,17-24,26-29 * page 1, paragraph 1 - page 5, paragraph 40 * * page 5, paragraph 43 - paragraph 45 *; | [X]WO2006021803 (CYCLACEL LTD [GB], et al) [X] 1-6,11,13-21,26,28-31 * claims 1-3,66 *; | [PX] - ROSSI ADRIANO G ET AL, "Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis", NATURE MEDICINE, (200609), vol. 12, no. 9, ISSN 1078-8956, pages 1056 - 1064, XP002466370 [PX] 1-31 * the whole document * DOI: http://dx.doi.org/10.1038/nm1468 | [X] - GUZI T, "CYC-202", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, (2004), vol. 5, no. 12, ISSN 1472-4472, pages 1311 - 1318, XP008042931 [X] 1-3,13-18,28-31 * page 1311, column LEFT, paragraph 3 - column RIGHT, paragraph 1 * | [X] - LINDROOS PM ET AL, "Regulation of PDGFR-alpha in rat pulmonary myofibroblasts by staurosporine", AMERICAN JOURNAL OF PHYSIOLOGY, (200102), vol. 280, no. 2/1, pages L354 - L362, XP008087891 [X] 1-3,6,8-10,13,14,17,18,21,23-25,28,29 * abstract * * page L354, column RIGHT, paragraph 2 * * page L360, column RIGHT, paragraph 3 * |